Extended Anticoagulant Treatment with Full- or Reduced-Dose Apixaban in Patients with Cancer-Associated Venous Thromboembolism: Rationale and Design of the API-CAT Study.
Mahé I, Agnelli G, Ay C, Bamias A, Becattini C, Carrier M, Chapelle C, Cohen AT, Girard P, Huisman MV, Klok FA, López-Núñez JJ, Maraveyas A, Mayeur D, Mir O, Monreal M, Righini M, Samama CM, Syrigos K, Szmit S, Torbicki A, Verhamme P, Vicaut E, Wang TF, Meyer G, Laporte S.
Mahé I, et al. Among authors: cohen at.
Thromb Haemost. 2022 Apr;122(4):646-656. doi: 10.1055/a-1647-9896. Epub 2021 Nov 5.
Thromb Haemost. 2022.
PMID: 34535037
Free PMC article.
Clinical Trial.